4 completed, 1 not yet recruiting, 1 recruiting, 1 unknown. 8 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 8 | Completed 4, Not yet recruiting 1, Recruiting 1, Unknown 1, Withdrawn 1 |
| Phase 2 | 1 | Completed 1 |
Follow Osteomyelitis: new trials by email Literature Review of Osteomyelitis trials Research Report on Osteomyelitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Prospective, Randomized, Multicenter Clinical Trial of Bisphosphonates Combined With Vancomycin for the Treatment of Cierny-Mader Type I and III Osteomyelitis Bisphosphonates Combined with Vancomycin, Vancomycin - Osteomyelitis (Refractory) | Phase 3 | Not yet recruiting | Second Affiliated Hospital, Zhejiang University, School of Medicine | 280 | 2026-05-01 | 2026-02-27 |
| Continuous Antibiotic Infusion In Children Benzylpenicillin - Infection | Phase 3 | Recruiting | Tampere University Hospital | 150 | 2026-04-21 | 2026-05-08 |
| Corticosteroids as an Additional Treatment for Mastoiditis In Children Dexamethasone, normal saline - Mastoiditis; Acute | Phase 3 | Unknown | ori snapiri | 50 | 2021-04-01 | 2021-04-06 |
| Dalbavancin vs Comparator in Pediatric Subjects With Acute Hematogenous Osteomyelitis Dalbavancin, cefazolin, nafcillin, oxacillin or vancomycin - Osteomyelitis | Phase 3 | Withdrawn | Durata Therapeutics International BV (an Affiliate of Actavis, Inc.) | 2016-03-01 | 2016-09-23 | |
| Oral Sodium Fusidate (CEM-102) for the Treatment of Staphylococcal Bone or Joint Infections sodium fusidate - Refractory Bone or Joint Infections | Phase 2 / Phase 3 | Completed | Arrevus Inc. | 30 | 2015-12-01 | 2020-01-30 |
| Ertapenem Sodium (MK-0826) Versus Piperacillin/Tazobactam Sodium for the Treatment of Diabetic Foot Infections in Chinese Adults (MK-0826-061) Ertapenem sodium, Piperacillin/tazobactam sodium, Piperacillin/tazobactam-matching placebo - Infection; Diabetic Foot | Phase 3 | Completed | Merck Sharp & Dohme LLC | 565 | 2011-09-02 | 2018-08-27 |
| Study Evaluating the Safety and Efficacy of a Once-daily Dose of Tigecycline vs Ertapenem in Diabetic Foot Infections (DFI) With a Substudy in Patients With Diabetic Foot Infections Complicated by Osteomyelitis. Tigecycline, Ertapenem - Bacterial Infections, Diabetic Foot | Phase 3 | Completed | Wyeth is now a wholly owned subsidiary of Pfizer | 1061 | 2007-01-01 | 2010-04-28 |
| Vancomycin Or Trimethoprim/Sulfamethoxazole for Methicillin-resistant Staphylococcus Aureus Osteomyelitis trimethoprim-sulfamethoxazole, vancomycin - Osteomyelitis, Methicillin-resistant Staphylococcus Aureus | Phase 3 | Completed | University of Washington | 2 | 2006-05-01 | 2023-04-11 |
Diabetes Complications (2) · Diabetic Foot (2) · Infections (2) · Bacterial Infections (1) · Cellulitis (1) · Diabetes Mellitus (1) · Foot Ulcer (1) · Mastoiditis (1) · Sepsis (1) · Soft Tissue Infections (1)
Bone Diseases (8) · Bone Diseases, Infectious (8) · Musculoskeletal Diseases (8) · Infections (6) · Cardiovascular Diseases (2) · Diabetic Angiopathies (2) · Diabetic Neuropathies (2) · Endocrine System Diseases (2) · Inflammation (2) · Leg Ulcer (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Skin Diseases (2) · Skin Ulcer (2) · Skin and Connective Tissue Diseases (2)
Vancomycin (3) · Ertapenem (2) · Piperacillin, Tazobactam Drug Combination (2) · Amoxicillin (1) · Cefazolin (1) · Cloxacillin (1) · Dexamethasone (1) · Fusidic Acid (1) · L 749345 (1) · Nafcillin (1) · Oxacillin (1) · Penicillin G (1) · Piperacillin (1) · Saline Solution (1) · Tazobactam (1)
Arrevus Inc. (1) · Durata Therapeutics International BV (an Affiliate of Actavis, Inc.) (1) · Merck Sharp & Dohme LLC (1) · Second Affiliated Hospital, Zhejiang University, School of Medicine (1) · Tampere University Hospital (1) · University of Washington (1) · Wyeth is now a wholly owned subsidiary of Pfizer (1) · ori snapiri (1)
United States (3) · China (2) · Finland (2) · Argentina (1) · Australia (1) · Austria (1) · Belgium (1) · Brazil (1) · Canada (1) · Chile (1) · Colombia (1) · Croatia (1) · Denmark (1) · Estonia (1) · France (1)
Alena Jamdourek, MD (1) · Christian Ramers, MD (1) · Jeanne Chan, PharmD, MPH (1) · Jeanne M Marrazzo, MD, MPH (1) · Lisa Taitsman, MD (1) · M. Bradford Henley, MD (1) · Matthew Golden, MD, MPH (1) · Robert D Harrington, MD (1) · Robert Dobbins, MD, PhD (1) · Thomas R Hawn, MD, PhD (1) · Timothy H. Dellitt, MD (1)
2025 (1)